Cognition following chimeric antigen receptor T-cell therapy: A systematic review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cognition following chimeric antigen receptor T-cell therapy: A systematic review
Authors
Keywords
-
Journal
JOURNAL OF AUTOIMMUNITY
Volume 140, Issue -, Pages 103126
Publisher
Elsevier BV
Online
2023-10-13
DOI
10.1016/j.jaut.2023.103126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies
- (2022) Adam D. Cohen et al. Blood Cancer Journal
- Long-Term Neurological Safety in B-Cell Lymphoma Patients Treated With Anti-CD19 CAR T-Cell Therapy
- (2022) Renata Ursu et al. NEUROLOGY
- Establishing construct validity of neuropsychological tests in cancer survivors
- (2022) Melissa Treviño et al. PSYCHO-ONCOLOGY
- Chimeric antigen receptor (CAR) T therapy and cognitive functions
- (2022) Brendan Bryan Jen-Wei Tan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Evaluation of mid-term (6-12 months) neurotoxicity in B-cell lymphoma patients treated with CAR T-cells: a prospective cohort study
- (2021) Didier Maillet et al. NEURO-ONCOLOGY
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. International Journal of Surgery
- Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma
- (2021) Michel Delforge et al. Blood Advances
- Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
- (2021) Rebecca Cheng et al. Oncology and Therapy
- Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy
- (2020) Cassie K. Chou et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Identification of neurotoxicity after chimeric antigen receptor (CAR) T-cell infusion without deterioration in the immune effector cell encephalopathy (ICE) score
- (2020) Megan M. Herr et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
- (2020) Kitsada Wudhikarn et al. Blood Advances
- Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy
- (2019) Julia Ruark et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy
- (2018) Haneen Shalabi et al. JOURNAL OF IMMUNOTHERAPY
- Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema
- (2018) Matthew Torre et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity
- (2013) Soo Young Kim et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
- (2011) Jeffrey S Wefel et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now